The early “Aβ hypothesis” and “tau hypothesis” were widely recognized at one time, but many drugs targeting Aβ and tau did not achieve the expected clinical efficacy, indicating that those two hypotheses cannot fully explain the pathogenesis of AD. This evidence concerns the gene MAPT and Alzheimer disease.